250 related articles for article (PubMed ID: 27577855)
1. Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle.
Bultot L; Jensen TE; Lai YC; Madsen AL; Collodet C; Kviklyte S; Deak M; Yavari A; Foretz M; Ghaffari S; Bellahcene M; Ashrafian H; Rider MH; Richter EA; Sakamoto K
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E706-E719. PubMed ID: 27577855
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators.
Lai YC; Kviklyte S; Vertommen D; Lantier L; Foretz M; Viollet B; Hallén S; Rider MH
Biochem J; 2014 Jun; 460(3):363-75. PubMed ID: 24665903
[TBL] [Abstract][Full Text] [Related]
3. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering.
Jørgensen NO; Kjøbsted R; Larsen MR; Birk JB; Andersen NR; Albuquerque B; Schjerling P; Miller R; Carling D; Pehmøller CK; Wojtaszewski JFP
Mol Metab; 2021 Sep; 51():101259. PubMed ID: 34033941
[TBL] [Abstract][Full Text] [Related]
4. PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.
Jensen TE; Ross FA; Kleinert M; Sylow L; Knudsen JR; Gowans GJ; Hardie DG; Richter EA
Biochem J; 2015 May; 467(3):461-72. PubMed ID: 25695398
[TBL] [Abstract][Full Text] [Related]
5. Compound- and fiber type-selective requirement of AMPKγ3 for insulin-independent glucose uptake in skeletal muscle.
Rhein P; Desjardins EM; Rong P; Ahwazi D; Bonhoure N; Stolte J; Santos MD; Ovens AJ; Ehrlich AM; Sanchez Garcia JL; Ouyang Q; Yabut JM; Kjolby M; Membrez M; Jessen N; Oakhill JS; Treebak JT; Maire P; Scott JW; Sanders MJ; Descombes P; Chen S; Steinberg GR; Sakamoto K
Mol Metab; 2021 Sep; 51():101228. PubMed ID: 33798773
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662.
Ducommun S; Ford RJ; Bultot L; Deak M; Bertrand L; Kemp BE; Steinberg GR; Sakamoto K
Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E688-96. PubMed ID: 24425763
[TBL] [Abstract][Full Text] [Related]
7. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
8. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
9. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
10. AICAR stimulation metabolome widely mimics electrical contraction in isolated rat epitrochlearis muscle.
Miyamoto L; Egawa T; Oshima R; Kurogi E; Tomida Y; Tsuchiya K; Hayashi T
Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1214-22. PubMed ID: 24088893
[TBL] [Abstract][Full Text] [Related]
11. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
12. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
[TBL] [Abstract][Full Text] [Related]
13. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle.
Fujii N; Hirshman MF; Kane EM; Ho RC; Peter LE; Seifert MM; Goodyear LJ
J Biol Chem; 2005 Nov; 280(47):39033-41. PubMed ID: 16186119
[TBL] [Abstract][Full Text] [Related]
15. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
[TBL] [Abstract][Full Text] [Related]
16. CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle.
Abbott MJ; Edelman AM; Turcotte LP
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1724-32. PubMed ID: 19812359
[TBL] [Abstract][Full Text] [Related]
17. Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle.
Vandanmagsar B; Yu Y; Simmler C; Dang TN; Kuhn P; Poulev A; Ribnicky DM; Pauli GF; Floyd ZE
Biomed Pharmacother; 2021 Nov; 143():112188. PubMed ID: 34563947
[TBL] [Abstract][Full Text] [Related]
18. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
19. The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport.
Knudsen JR; Madsen AB; Persson KW; Henríquez-Olguín C; Li Z; Jensen TE
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231045
[TBL] [Abstract][Full Text] [Related]
20. Effect of fiber type and nutritional state on AICAR- and contraction-stimulated glucose transport in rat muscle.
Ai H; Ihlemann J; Hellsten Y; Lauritzen HP; Hardie DG; Galbo H; Ploug T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1291-300. PubMed ID: 12006359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
